Information  X 
Enter a valid email address

Lamprell plc (LAM)

  Print      Mail a friend       Annual reports

Tuesday 22 October, 2019

Lamprell plc

Investor and analyst site visit

RNS Number : 6692Q
Lamprell plc
22 October 2019
 

 

 

22 October 2019

 

 

LAMPRELL PLC
("Lamprell" and with its subsidiaries the "Group")

 

INVESTOR AND ANALYST SITE VISIT

 

 

The management presentation from the analyst and investor trip to Lamprell's Hamriyah facility in the UAE today is now available for download at the Company's website, www.lamprell.com.  The presentation, which contains no new material information, contains an overview of Lamprell's business operations and its growth strategy.

 

 

- Ends -

 

 

Enquiries:

 

Lamprell plc

 

Maria Babkina, Investor Relations

+44 (0) 7852 618 046



 

Tulchan Communications, London

+44 (0) 207 353 4200

Martin Robinson


Martin Pengelley




 

Notes to editors

Lamprell PLC, based in the United Arab Emirates ("UAE") and with over 40 years' experience, is a leading provider of fabrication, engineering and contracting services to the offshore and onshore oil & gas and renewable energy industries.  The Group has established leading market positions in the fabrication of shallow-water drilling jackup rigs, liftboats, land rigs, and rig refurbishment projects, and it also has an international reputation for building complex offshore and onshore process modules and fixed platforms.

 

Lamprell employs around 5,000 people across multiple facilities, with its primary facilities located in Hamriyah, Sharjah and Jebel Ali, all of which are in the UAE. In addition, the Group has facilities in Saudi Arabia (through a joint venture agreement). Combined, the Group's facilities cover approximately 828,000 m2 with 1.6 km of quayside.

 

Lamprell is listed on the London Stock Exchange (symbol "LAM").


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCFESSLEFUSELS

a d v e r t i s e m e n t